According to the NIMH, Approximately 21 million adults in the United States experienced a major depressive episode, accounting for 8.4% of the adult population. Women were more likely to experience depression, with a rate of 10.5%, while the rate among men was 6.2%. While traditional treatments such as therapy and antidepressants have helped many people manage their symptoms, some individuals struggle to find relief. For these individuals, there is a new treatment option available called SPRAVATO. SPRAVATO (esketamine) is a nasal spray that was approved by the FDA in 2019 for the treatment of treatment-resistant depression. This means that it is intended for individuals who have not responded to traditional treatments such as therapy and/or at least two different antidepressants. So what exactly is SPRAVATO, and how does it work? This article will review the benefits of SPRAVATO and what it can do for you.
SPRAVATO is a type of ketamine, which is a fast-acting and well-established anesthetic and pain reliever. While the exact mechanism of action is not yet fully understood, it is thought that SPRAVATO helps to restore balance to certain chemicals in the brain that are involved in regulating mood, such as glutamate and GABA.
One of the key benefits of SPRAVATO is its rapid onset of action. Unlike traditional antidepressants, which can take several weeks or even months to take effect, many patients report feeling an improvement in their symptoms within just a few hours after receiving SPRAVATO. This rapid relief can be especially important for individuals who are struggling with severe and debilitating symptoms, as it can help to provide them with the hope and motivation needed to continue with their treatment.
In addition to its rapid onset of action, SPRAVATO is also well-tolerated by most patients. The most common side effects are temporary and mild, and include dizziness, nausea, and headache. Furthermore, because SPRAVATO is administered under the supervision of a healthcare professional, the risk of abuse and addiction is low.
It is important to note that SPRAVATO is not a standalone treatment for depression, but is intended to be used in conjunction with an ongoing treatment plan that may include therapy, medications, and/or lifestyle changes. However, for individuals who have not responded to other treatments, SPRAVATO can provide a new and effective option that can help to improve their symptoms and overall quality of life.
If you or a loved one is struggling with treatment-resistant depression, SPRAVATO may be a viable option to consider. To learn more about SPRAVATO and whether it may be right for you, we encourage you to get in touch with us today at info@psyfitms.com. Psyfi TMS is dedicated to providing the highest quality of care and support to help individuals manage their symptoms and lead a happier and more fulfilling life.
